{"id":350211,"date":"2020-07-01T10:09:06","date_gmt":"2020-07-01T16:09:06","guid":{"rendered":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/?p=350211"},"modified":"2020-07-01T10:09:06","modified_gmt":"2020-07-01T16:09:06","slug":"desarrollan-un-nuevo-tratamiento-con-efectos-de-larga-duracion-para-el-vih","status":"publish","type":"post","link":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/hogar\/salud\/desarrollan-un-nuevo-tratamiento-con-efectos-de-larga-duracion-para-el-vih","title":{"rendered":"Desarrollan un nuevo tratamiento con efectos de larga duraci\u00f3n para el VIH"},"content":{"rendered":"<p>Cient\u00edficos estadounidenses han desarrollado un nuevo agente antirretroviral con efectos de larga duraci\u00f3n que puede ayudar en el tratamiento para la infecci\u00f3n por VIH, el virus que causa la enfermedad del Sida, seg\u00fan informa este mi\u00e9rcoles 1 de julio la revista Nature.<\/p>\n<p>La mol\u00e9cula, nombrada por los investigadores como GS-6207, <strong>aumenta las opciones de \u00e9xito entre aquellos pacientes con cepas de VIH resistentes a otros medicamentos<\/strong>, adem\u00e1s de facilitar el proceso de adhesi\u00f3n al tratamiento entre aquellos que tienen complicaciones para seguir la frecuencia de las dosis diarias.<\/p>\n<p>Dise\u00f1ado por el equipo del investigador de la compa\u00f1\u00eda biotecnol\u00f3gica estadounidense Gilead Sciences Stephen Yant, el agente GS-6207 reduce la carga viral en los pacientes tras una sola dosis y permanece activo en el cuerpo hasta m\u00e1s de seis meses despu\u00e9s de su administraci\u00f3n.<\/p>\n<p><strong>Esta peque\u00f1a mol\u00e9cula, que ha de inyectarse por v\u00eda subcut\u00e1nea, es un activo \u201cgeneralmente seguro y bien tolerado&#8221;<\/strong>, seg\u00fan indican los resultados preliminares de un estudio cl\u00ednico realizado a 40 personas sanas.<\/p>\n<p>En una investigaci\u00f3n de prueba de concepto posterior, en el que participaron 32 pacientes con infecci\u00f3n por VIH-1 sin tratamiento, el compuesto consigui\u00f3 reducir la carga viral nueve d\u00edas despu\u00e9s de su administraci\u00f3n mediante una dosis \u00fanica, aunque no logr\u00f3 su eliminaci\u00f3n total.<\/p>\n<p>El agente GS-6207, se\u00f1alan los autores, altera la c\u00e1pside del VIH, la cubierta proteica que encierra el genoma del virus, de forma que consigue interferir con m\u00faltiples interacciones que son esenciales para su replicaci\u00f3n.<\/p>\n<p>La mayor\u00eda de f\u00e1rmacos antirretrovirales desarrollados a partir de peque\u00f1as mol\u00e9culas funciona al confrontar con las enzimas virales, sin embargo, la intervenci\u00f3n sobre esta estructura proteica puede ser una \u201ccamino prometedor\u201d para el tratamiento de la infecci\u00f3n por VIH.<\/p>\n<p><strong>Asimismo, el estudio sugiere que la acci\u00f3n prolongada de la GS-6207 podr\u00eda convertir a esta mol\u00e9cula en una buena candidata para prevenir la infecci\u00f3n por VIH<\/strong> en poblaci\u00f3n de riesgo, aunque esta hip\u00f3tesis a\u00fan no ha sido comprobada por los investigadores. EFE<\/p>\n<figure id=\"attachment_350217\" aria-describedby=\"caption-attachment-350217\" style=\"width: 688px\" class=\"wp-caption alignnone\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-350217 size-full\" src=\"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/wp-content\/uploads\/sites\/2\/2020\/07\/PRUEBAS-DE-SIDA-WD.png\" alt=\"\" width=\"688\" height=\"390\" srcset=\"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/wp-content\/uploads\/sites\/2\/2020\/07\/PRUEBAS-DE-SIDA-WD.png 688w, https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/wp-content\/uploads\/sites\/2\/2020\/07\/PRUEBAS-DE-SIDA-WD.png?resize=300,170 300w, https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/wp-content\/uploads\/sites\/2\/2020\/07\/PRUEBAS-DE-SIDA-WD.png?resize=260,146 260w, https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/wp-content\/uploads\/sites\/2\/2020\/07\/PRUEBAS-DE-SIDA-WD.png?resize=150,85 150w\" sizes=\"auto, (max-width: 688px) 100vw, 688px\" \/><figcaption id=\"caption-attachment-350217\" class=\"wp-caption-text\">Muchos estudios buscan conocer c\u00f3mo se puede aumentar la esperanza de vida en pacientes con VIH. (Foto: Hemeroteca PL)<\/figcaption><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>La mol\u00e9cula GS-6207 aumenta las opciones de \u00e9xito entre aquellos pacientes con cepas de VIH.<\/p>\n","protected":false},"author":86,"featured_media":350215,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_hide_featured_image":false,"_jetpack_featured_image_duplicate_dismissed":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_post_was_ever_published":false},"categories":[39738,39763],"etiqueta":[27351,20743,22446],"class_list":["post-350211","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-hogar","category-salud","etiqueta-sida","etiqueta-tratamientos","etiqueta-vih"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Desarrollan un nuevo tratamiento con efectos de larga duraci\u00f3n para el VIH - Guatevision<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/hogar\/salud\/desarrollan-un-nuevo-tratamiento-con-efectos-de-larga-duracion-para-el-vih\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Desarrollan un nuevo tratamiento con efectos de larga duraci\u00f3n para el VIH - Guatevision\" \/>\n<meta property=\"og:description\" content=\"La mol\u00e9cula GS-6207 aumenta las opciones de \u00e9xito entre aquellos pacientes con cepas de VIH.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/hogar\/salud\/desarrollan-un-nuevo-tratamiento-con-efectos-de-larga-duracion-para-el-vih\" \/>\n<meta property=\"og:site_name\" content=\"Guatevision\" \/>\n<meta property=\"article:published_time\" content=\"2020-07-01T16:09:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/wp-content\/uploads\/sites\/2\/2020\/07\/Estudio-VIH-3.jpg?quality=82\" \/>\n\t<meta property=\"og:image:width\" content=\"760\" \/>\n\t<meta property=\"og:image:height\" content=\"430\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Oscar Garc\u00eda\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Oscar Garc\u00eda\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/prensalibre-com-develop.go-vip.co\\\/guatevision\\\/hogar\\\/salud\\\/desarrollan-un-nuevo-tratamiento-con-efectos-de-larga-duracion-para-el-vih#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/prensalibre-com-develop.go-vip.co\\\/guatevision\\\/hogar\\\/salud\\\/desarrollan-un-nuevo-tratamiento-con-efectos-de-larga-duracion-para-el-vih\"},\"author\":{\"name\":\"Oscar Garc\u00eda\",\"@id\":\"https:\\\/\\\/prensalibre-com-develop.go-vip.co\\\/guatevision\\\/#\\\/schema\\\/person\\\/23d12c2e4788a05b94cead5a7bcd6332\"},\"headline\":\"Desarrollan un nuevo tratamiento con efectos de larga duraci\u00f3n para el VIH\",\"datePublished\":\"2020-07-01T16:09:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/prensalibre-com-develop.go-vip.co\\\/guatevision\\\/hogar\\\/salud\\\/desarrollan-un-nuevo-tratamiento-con-efectos-de-larga-duracion-para-el-vih\"},\"wordCount\":402,\"publisher\":{\"@id\":\"https:\\\/\\\/prensalibre-com-develop.go-vip.co\\\/guatevision\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/prensalibre-com-develop.go-vip.co\\\/guatevision\\\/hogar\\\/salud\\\/desarrollan-un-nuevo-tratamiento-con-efectos-de-larga-duracion-para-el-vih#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/prensalibre-com-develop.go-vip.co\\\/guatevision\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2020\\\/07\\\/Estudio-VIH-3.jpg\",\"articleSection\":[\"Hogar\",\"Salud\"],\"inLanguage\":\"es-GT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/prensalibre-com-develop.go-vip.co\\\/guatevision\\\/hogar\\\/salud\\\/desarrollan-un-nuevo-tratamiento-con-efectos-de-larga-duracion-para-el-vih\",\"url\":\"https:\\\/\\\/prensalibre-com-develop.go-vip.co\\\/guatevision\\\/hogar\\\/salud\\\/desarrollan-un-nuevo-tratamiento-con-efectos-de-larga-duracion-para-el-vih\",\"name\":\"Desarrollan un nuevo tratamiento con efectos de larga duraci\u00f3n para el VIH - Guatevision\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/prensalibre-com-develop.go-vip.co\\\/guatevision\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/prensalibre-com-develop.go-vip.co\\\/guatevision\\\/hogar\\\/salud\\\/desarrollan-un-nuevo-tratamiento-con-efectos-de-larga-duracion-para-el-vih#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/prensalibre-com-develop.go-vip.co\\\/guatevision\\\/hogar\\\/salud\\\/desarrollan-un-nuevo-tratamiento-con-efectos-de-larga-duracion-para-el-vih#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/prensalibre-com-develop.go-vip.co\\\/guatevision\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2020\\\/07\\\/Estudio-VIH-3.jpg\",\"datePublished\":\"2020-07-01T16:09:06+00:00\",\"inLanguage\":\"es-GT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/prensalibre-com-develop.go-vip.co\\\/guatevision\\\/hogar\\\/salud\\\/desarrollan-un-nuevo-tratamiento-con-efectos-de-larga-duracion-para-el-vih\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es-GT\",\"@id\":\"https:\\\/\\\/prensalibre-com-develop.go-vip.co\\\/guatevision\\\/hogar\\\/salud\\\/desarrollan-un-nuevo-tratamiento-con-efectos-de-larga-duracion-para-el-vih#primaryimage\",\"url\":\"https:\\\/\\\/prensalibre-com-develop.go-vip.co\\\/guatevision\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2020\\\/07\\\/Estudio-VIH-3.jpg\",\"contentUrl\":\"https:\\\/\\\/prensalibre-com-develop.go-vip.co\\\/guatevision\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2020\\\/07\\\/Estudio-VIH-3.jpg\",\"width\":760,\"height\":430,\"caption\":\"Muchos estudios buscan conocer c\u00f3mo se puede aumentar la esperanza de vida en pacientes con VIH. (Foto: Hemeroteca PL)\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/prensalibre-com-develop.go-vip.co\\\/guatevision\\\/#website\",\"url\":\"https:\\\/\\\/prensalibre-com-develop.go-vip.co\\\/guatevision\\\/\",\"name\":\"Guatevision\",\"description\":\"\u00a1Enciende Lo Bueno!\",\"publisher\":{\"@id\":\"https:\\\/\\\/prensalibre-com-develop.go-vip.co\\\/guatevision\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/prensalibre-com-develop.go-vip.co\\\/guatevision\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es-GT\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/prensalibre-com-develop.go-vip.co\\\/guatevision\\\/#organization\",\"name\":\"Guatevision\",\"url\":\"https:\\\/\\\/prensalibre-com-develop.go-vip.co\\\/guatevision\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es-GT\",\"@id\":\"https:\\\/\\\/prensalibre-com-develop.go-vip.co\\\/guatevision\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/prensalibre-com-develop.go-vip.co\\\/guatevision\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2026\\\/04\\\/Diseno-sin-titulo.png\",\"contentUrl\":\"https:\\\/\\\/prensalibre-com-develop.go-vip.co\\\/guatevision\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2026\\\/04\\\/Diseno-sin-titulo.png\",\"width\":1000,\"height\":600,\"caption\":\"Guatevision\"},\"image\":{\"@id\":\"https:\\\/\\\/prensalibre-com-develop.go-vip.co\\\/guatevision\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/prensalibre-com-develop.go-vip.co\\\/guatevision\\\/#\\\/schema\\\/person\\\/23d12c2e4788a05b94cead5a7bcd6332\",\"name\":\"Oscar Garc\u00eda\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es-GT\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1279253bb5b7bef9fd9c2b07a1380d08028943a6a06c009624851b3676e28280?s=96&d=mm&r=g4a24b0593b9f227bb8212c8c8267ee8d\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1279253bb5b7bef9fd9c2b07a1380d08028943a6a06c009624851b3676e28280?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1279253bb5b7bef9fd9c2b07a1380d08028943a6a06c009624851b3676e28280?s=96&d=mm&r=g\",\"caption\":\"Oscar Garc\u00eda\"},\"url\":\"https:\\\/\\\/prensalibre-com-develop.go-vip.co\\\/guatevision\\\/author\\\/ogarcia\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Desarrollan un nuevo tratamiento con efectos de larga duraci\u00f3n para el VIH - Guatevision","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/hogar\/salud\/desarrollan-un-nuevo-tratamiento-con-efectos-de-larga-duracion-para-el-vih","og_locale":"es_ES","og_type":"article","og_title":"Desarrollan un nuevo tratamiento con efectos de larga duraci\u00f3n para el VIH - Guatevision","og_description":"La mol\u00e9cula GS-6207 aumenta las opciones de \u00e9xito entre aquellos pacientes con cepas de VIH.","og_url":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/hogar\/salud\/desarrollan-un-nuevo-tratamiento-con-efectos-de-larga-duracion-para-el-vih","og_site_name":"Guatevision","article_published_time":"2020-07-01T16:09:06+00:00","og_image":[{"width":760,"height":430,"url":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/wp-content\/uploads\/sites\/2\/2020\/07\/Estudio-VIH-3.jpg?quality=82","type":"image\/jpeg"}],"author":"Oscar Garc\u00eda","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Oscar Garc\u00eda","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/hogar\/salud\/desarrollan-un-nuevo-tratamiento-con-efectos-de-larga-duracion-para-el-vih#article","isPartOf":{"@id":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/hogar\/salud\/desarrollan-un-nuevo-tratamiento-con-efectos-de-larga-duracion-para-el-vih"},"author":{"name":"Oscar Garc\u00eda","@id":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/#\/schema\/person\/23d12c2e4788a05b94cead5a7bcd6332"},"headline":"Desarrollan un nuevo tratamiento con efectos de larga duraci\u00f3n para el VIH","datePublished":"2020-07-01T16:09:06+00:00","mainEntityOfPage":{"@id":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/hogar\/salud\/desarrollan-un-nuevo-tratamiento-con-efectos-de-larga-duracion-para-el-vih"},"wordCount":402,"publisher":{"@id":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/#organization"},"image":{"@id":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/hogar\/salud\/desarrollan-un-nuevo-tratamiento-con-efectos-de-larga-duracion-para-el-vih#primaryimage"},"thumbnailUrl":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/wp-content\/uploads\/sites\/2\/2020\/07\/Estudio-VIH-3.jpg","articleSection":["Hogar","Salud"],"inLanguage":"es-GT"},{"@type":"WebPage","@id":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/hogar\/salud\/desarrollan-un-nuevo-tratamiento-con-efectos-de-larga-duracion-para-el-vih","url":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/hogar\/salud\/desarrollan-un-nuevo-tratamiento-con-efectos-de-larga-duracion-para-el-vih","name":"Desarrollan un nuevo tratamiento con efectos de larga duraci\u00f3n para el VIH - Guatevision","isPartOf":{"@id":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/#website"},"primaryImageOfPage":{"@id":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/hogar\/salud\/desarrollan-un-nuevo-tratamiento-con-efectos-de-larga-duracion-para-el-vih#primaryimage"},"image":{"@id":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/hogar\/salud\/desarrollan-un-nuevo-tratamiento-con-efectos-de-larga-duracion-para-el-vih#primaryimage"},"thumbnailUrl":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/wp-content\/uploads\/sites\/2\/2020\/07\/Estudio-VIH-3.jpg","datePublished":"2020-07-01T16:09:06+00:00","inLanguage":"es-GT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/hogar\/salud\/desarrollan-un-nuevo-tratamiento-con-efectos-de-larga-duracion-para-el-vih"]}]},{"@type":"ImageObject","inLanguage":"es-GT","@id":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/hogar\/salud\/desarrollan-un-nuevo-tratamiento-con-efectos-de-larga-duracion-para-el-vih#primaryimage","url":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/wp-content\/uploads\/sites\/2\/2020\/07\/Estudio-VIH-3.jpg","contentUrl":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/wp-content\/uploads\/sites\/2\/2020\/07\/Estudio-VIH-3.jpg","width":760,"height":430,"caption":"Muchos estudios buscan conocer c\u00f3mo se puede aumentar la esperanza de vida en pacientes con VIH. (Foto: Hemeroteca PL)"},{"@type":"WebSite","@id":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/#website","url":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/","name":"Guatevision","description":"\u00a1Enciende Lo Bueno!","publisher":{"@id":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es-GT"},{"@type":"Organization","@id":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/#organization","name":"Guatevision","url":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/","logo":{"@type":"ImageObject","inLanguage":"es-GT","@id":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/#\/schema\/logo\/image\/","url":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/wp-content\/uploads\/sites\/2\/2026\/04\/Diseno-sin-titulo.png","contentUrl":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/wp-content\/uploads\/sites\/2\/2026\/04\/Diseno-sin-titulo.png","width":1000,"height":600,"caption":"Guatevision"},"image":{"@id":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/#\/schema\/person\/23d12c2e4788a05b94cead5a7bcd6332","name":"Oscar Garc\u00eda","image":{"@type":"ImageObject","inLanguage":"es-GT","@id":"https:\/\/secure.gravatar.com\/avatar\/1279253bb5b7bef9fd9c2b07a1380d08028943a6a06c009624851b3676e28280?s=96&d=mm&r=g4a24b0593b9f227bb8212c8c8267ee8d","url":"https:\/\/secure.gravatar.com\/avatar\/1279253bb5b7bef9fd9c2b07a1380d08028943a6a06c009624851b3676e28280?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1279253bb5b7bef9fd9c2b07a1380d08028943a6a06c009624851b3676e28280?s=96&d=mm&r=g","caption":"Oscar Garc\u00eda"},"url":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/author\/ogarcia"}]}},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/wp-content\/uploads\/sites\/2\/2020\/07\/Estudio-VIH-3.jpg","_links":{"self":[{"href":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/wp-json\/wp\/v2\/posts\/350211","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/wp-json\/wp\/v2\/users\/86"}],"replies":[{"embeddable":true,"href":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/wp-json\/wp\/v2\/comments?post=350211"}],"version-history":[{"count":0,"href":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/wp-json\/wp\/v2\/posts\/350211\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/wp-json\/wp\/v2\/media\/350215"}],"wp:attachment":[{"href":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/wp-json\/wp\/v2\/media?parent=350211"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/wp-json\/wp\/v2\/categories?post=350211"},{"taxonomy":"etiqueta","embeddable":true,"href":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/wp-json\/wp\/v2\/etiqueta?post=350211"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}